CollPlant to Raise $2M Through Sale of 1.6M Shares at $1.25
CollPlant will sell 1.6 million ordinary shares at $1.25 per share in a registered direct offering to raise $2.0 million in gross proceeds. The company plans to apply the capital toward its ongoing collagen-based product development and general corporate purposes.
1. Offering Details
CollPlant has initiated a registered direct offering of 1.6 million ordinary shares priced at $1.25 each, targeting gross proceeds of $2.0 million. The shares will be sold to institutional and accredited investors, subject to customary closing conditions.
2. Financial Impact
Proceeds from the offering are earmarked to bolster CollPlant’s cash position and fund its collagen-based tissue engineering pipeline. The issuance will increase the company’s share count, resulting in dilution for existing shareholders.